Supreme Court keeps broader access to abortion pill mifepristone in place while legal fight continues
The Supreme Court kept broader access to abortion pill mifepristone in place, allowing telehealth prescribing and mail delivery to continue.

The Supreme Court ruled on Thursday that the abortion pill mifepristone can continue to be prescribed online or over the phone and sent through the mail.
The Supreme Court kept broader access to abortion pill mifepristone in place, allowing telehealth prescribing and mail delivery to continue.
Louisiana had sued the FDA in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotelySign up for the Breaking News US newsletter emailThe US supreme court upheld nationwide access to mail-order mifepristone, an abortion medication, in a shadow-docket decision on Thursday.Louisiana sued the US Food and Drug Administration (FDA)…
The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order that blocked abortion providers from prescribing the widely used drug through telehealth and shipping it to patients.
A divided Supreme Court on Thursday indefinitely extended a freeze on strict new restrictions for dispensing the widely used abortion pill mifepristone while an underlying legal fight over the drug plays out.Why it matters: The widely expected order provides legal certainty for pharmacies, telehealth companies and clinicians caught up in the latest battle…
A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.
The US Supreme Court let a widely used abortion pill continue to be dispensed by mail, putting on hold a federal appeals court decision that had briefly required patients to make an in-person visit to a provider. Kailey Leinz and Joe Mathieu report on "Balance of Power: Evening Edition." (Source: Bloomberg)
The high court’s decision allows providers to continue sending common abortion drug mifepristone to patients by mail.
The Supreme Court restored access on Thursday to mail-order abortion pills nationwide, lifting an appeals court’s block on a 2023 FDA rule which had removed the in-person requirement for mifepristone. In an unsigned order, the high court ruled 7-2 in favor of issuing a stay, which indefinitely pauses a May 1 ruling by the U.S.…